The FDA will allow plasma from coronavirus survivors to be used to treat critically ill patients, as the practice has shown success with other infections.
'We are also consulting with physicians treating COVID-19 patients and are not aware of reports of any negative effects of ibuprofen, beyond the usual known side effects that limit its use in certain populations.'